BioRelix's Debt - II Round

BioRelix raised a round of funding on March 13, 2012.

BioRelix is discovering and developing new treatments for infectious diseases that target RiboSwitches, a class of RNA drug targets found in pathogenic bacteria and fungi. Riboswitches are short stret…

Articles about BioRelix's Debt - II Round: